| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/29/2011 | CN102112135A Vaccine composition containing synthetic adjuvant |
| 06/29/2011 | CN102108368A Recombinant saccharomyces cerevisiae expressing mycobacterium tuberculosis antigen and preparation method thereof |
| 06/29/2011 | CN102108355A Multi-epitope artificial antigen of plasmodium falciparum and application thereof |
| 06/29/2011 | CN102108336A Recombinant adenovirus vaccine containing EB (Epstein-Barr) virus membrane protein gp350/220, gp85, gp78 or gp25 gene |
| 06/29/2011 | CN102107004A Porcine reproductive and respiratory syndrome virus-like particle vaccine and preparation method thereof |
| 06/29/2011 | CN102107003A Porcine reproductive and respiratory syndrome Virosome vaccine and preparation method thereof |
| 06/29/2011 | CN101579528B HIV composite multi-epitope DNA vaccine and application thereof |
| 06/29/2011 | CN101289496B Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses |
| 06/29/2011 | CN101288771B Preparation method of anti-human Nogo-66 receptor protein vaccine and application thereof |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/28/2011 | US7968695 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 06/28/2011 | US7968694 Tuberculosis antigen detection assays and vaccines |
| 06/28/2011 | US7968690 Agonist anti-trkC antibodies and methods using same |
| 06/28/2011 | US7968688 Antibodies that bind to the C35 polypeptide |
| 06/28/2011 | US7968685 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer |
| 06/28/2011 | US7968684 Polypeptides comprising antigen binding domains for diagnosis, prevention and treatment of inflammation, skin, respiratory, kidney, cardiovascular, nervous system and pancreatic disorder |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968676 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 06/28/2011 | US7968518 Use of modified cyclosporins for the treatment of HCV disorders |
| 06/28/2011 | US7968512 Conjugates that contain the homeodomain of antennapedia |
| 06/28/2011 | US7968332 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/28/2011 | US7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 06/28/2011 | US7968297 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968283 Gene expressed in prostate cancer |
| 06/28/2011 | US7968106 ABFB-1 gene of penicillium funiculosum |
| 06/28/2011 | US7968105 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 06/28/2011 | US7968104 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/28/2011 | US7968103 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 06/28/2011 | US7968102 Dengue chimeric viruses |
| 06/28/2011 | US7968101 Recombinant influenza vectors with tandem transcription units |
| 06/28/2011 | US7968100 Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | US7968097 Identification of Hla-A2-presented T-cell epitopes derived from the oncofoetal antigen-immature laminin receptor protein and uses thereof |
| 06/28/2011 | US7968096 Methods and compositions for treating toxoplasma |
| 06/28/2011 | US7968094 Use of anti-tissue factor antibodies for treating thromboses |
| 06/28/2011 | US7968093 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/28/2011 | US7968092 Human binding molecule against CD1a |
| 06/28/2011 | US7968091 Methods and compositions to regulate iron metabolism |
| 06/28/2011 | US7968090 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
| 06/28/2011 | CA2414772C Prevention and treatment of alzheimer's disease |
| 06/28/2011 | CA2400182C Full-length infectious cdna clones of tick borne flavivirus |
| 06/28/2011 | CA2331641C Multivalent antibody constructs |
| 06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
| 06/28/2011 | CA2209300C Redirection of cellular immunity by receptor chimeras |
| 06/28/2011 | CA1341617C Inhibin isolated from ovarian follicular fluid |
| 06/23/2011 | WO2011075606A2 Hyperglycosylated polypeptide variants and methods of use |
| 06/23/2011 | WO2011075578A1 Methods of treating interstitial cystitis |
| 06/23/2011 | WO2011075516A2 Active scaffolds for on-demand drug and cell delivery |
| 06/23/2011 | WO2011075379A1 Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| 06/23/2011 | WO2011075255A1 Uniform field magnetization and targeting of therapeutic formulations |
| 06/23/2011 | WO2011075085A1 Method for identifying virulence of plasmodium falciparum isolates |
| 06/23/2011 | WO2011075035A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy |
| 06/23/2011 | WO2011074965A1 Methods and means for counteracting an activity of an fc domain |
| 06/23/2011 | WO2011074929A1 A recombinant a/astanarg/5:3/2009 m-13-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu |
| 06/23/2011 | WO2011074928A1 A recombinant a/astanarg/6:2/2009 m-12-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu |
| 06/23/2011 | WO2011074711A1 ADJUVANT CONTAINING β-HEMATIN |
| 06/23/2011 | WO2011074006A2 Vaccine composition |
| 06/23/2011 | WO2011073692A1 Proteins, nucleic acid molecules and compositions |
| 06/23/2011 | WO2011073630A2 Parasite vaccine |
| 06/23/2011 | WO2011073521A1 Methods for enriching adult-derived endothelial progenitor cells and uses thereof |
| 06/23/2011 | WO2011073473A1 Vinyl sulphone functionalised lipid systems. synthesis and uses |
| 06/23/2011 | WO2011073215A2 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| 06/23/2011 | WO2011072875A1 Fusion polypeptides and their use for prevention and treatment of cancer |
| 06/23/2011 | WO2011072501A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 06/23/2011 | WO2011050168A9 Rsv immunogens, antibodies and compositions thereof |
| 06/23/2011 | WO2011045573A3 Staphylococcal antigens |
| 06/23/2011 | WO2011044698A8 Multi epitope vaccine for poultry |
| 06/23/2011 | WO2011028961A3 Anti-botulism antibody coformulations |
| 06/23/2011 | WO2011028888A3 Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity |
| 06/23/2011 | WO2011027990A9 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
| 06/23/2011 | WO2011022394A3 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 06/23/2011 | WO2011018504A3 Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| 06/23/2011 | WO2011014863A3 Prophylaxis against cancer metastasis |
| 06/23/2011 | WO2010077473A8 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 06/23/2011 | WO2010061193A3 Compositions with reduced dimer formation |
| 06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151015 Immunomodulator particles and methods of treating |
| 06/23/2011 | US20110150987 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance |
| 06/23/2011 | US20110150982 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 06/23/2011 | US20110150979 Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150966 Degradable polymers incorporating gamma-butyrolactone |
| 06/23/2011 | US20110150940 Dry powder compositions and systems for poultry vaccination |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
| 06/23/2011 | US20110150936 Anti-tumoral cells |
| 06/23/2011 | US20110150935 Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancers |
| 06/23/2011 | US20110150934 Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer |
| 06/23/2011 | US20110150933 Cattle vaccines |
| 06/23/2011 | US20110150932 Constructing a DNA Chimera for Vaccine Development Against Leishmaniasis and Tuberculosis |
| 06/23/2011 | US20110150931 Rapid responses to delayed booster immunisations |
| 06/23/2011 | US20110150930 Recombinant viral-based malaria vaccines |
| 06/23/2011 | US20110150929 SARS vaccine compositions and methods of making and using them |
| 06/23/2011 | US20110150928 Unique avian reoviridae |
| 06/23/2011 | US20110150927 Stabilisation of Viral Microparticles |
| 06/23/2011 | US20110150926 Influenza vaccines |
| 06/23/2011 | US20110150925 Cell-based systems for producing influenza vaccines |